{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:42:35Z","timestamp":1790188955402,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RC-2025-2797524"],"award-info":[{"award-number":["RC-2025-2797524"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastrointestinal stromal tumors (GISTs) are primarily treated with tyrosine kinase inhibitors (TKIs) such as imatinib. However, the development of drug resistance remains a critical clinical challenge, highlighting the urgent need for novel therapeutic agents with alternative mechanisms of action. This study aimed to identify and characterize new small molecules effective against imatinib-sensitive and resistant GISTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A library of 27 benzo[d]imidazo[2,1-b]thiazole derivatives was synthesized and screened for cytotoxicity against four GIST cell lines, including imatinib-sensitive (GIST-T1, GIST-882) and imatinib-resistant (GIST-48, GIST-48B) models. The most effective compound, MBT3T, was further evaluated for safety on healthy cells (PBMCs, fibroblasts) and mechanism of action using computational docking, immunofluorescence, and flow cytometry. Efficacy was validated both in 3D bioprinted tumor models and in vivo using zebrafish xenografts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MBT3T exhibited potent nanomolar cytotoxicity across all GIST cell lines while maintaining a favorable safety profile on healthy cells. Mechanistic studies revealed that MBT3T acts independently of the KIT signaling pathway, targeting tubulin at the colchicine-binding site. This interaction caused microtubule disassembly, leading to G2\/M cell cycle arrest and caspase-mediated apoptosis. In in vivo zebrafish assays, MBT3T significantly reduced tumor growth in both imatinib-sensitive and resistant xenografts without inducing systemic toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We identified MBT3T as a novel, selective tubulin polymerization inhibitor. Its ability to bypass TKIs resistance mechanisms suggests it may represent a promising therapeutic candidate for the treatment of refractory GISTs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03698-3","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:55:51Z","timestamp":1774097751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of MBT3T as a new effective therapeutic option in imatinib-resistant gastrointestinal stromal tumors (GISTs)"],"prefix":"10.1186","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7774-402X","authenticated-orcid":false,"given":"Gloria","family":"Ravegnini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tainah Dorina","family":"Marforio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Coschina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Benuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Samaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Di Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Hrelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Calvaresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Facchinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Morigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"3698_CR1","doi-asserted-by":"publisher","unstructured":"Mei L, Smith SC, Faber AC, Trent J, Grossman SR, Stratakis CA et al. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine. Trends Cancer. Trends Cancer. 2018;4:74\u201391. https:\/\/doi.org\/10.1016\/J.TRECAN.2017.11.006.\u00a0Cited 24 Jul 2024.","DOI":"10.1016\/J.TRECAN.2017.11.006"},{"key":"3698_CR2","doi-asserted-by":"publisher","unstructured":"Ravegnini G, Sammarini G, Angelini S, Hrelia P. Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia. Expert Opin Drug Metab Toxicol. Expert Opin Drug Metab Toxicol; 2016;12:733\u201342. https:\/\/doi.org\/10.1080\/17425255.2016.1184649.\u00a0 Cited 17 Jul 2024.","DOI":"10.1080\/17425255.2016.1184649"},{"key":"3698_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12967-017-1212-x","volume":"15","author":"M Nannini","year":"2017","unstructured":"Nannini M, Urbini M, Astolfi A, Biasco G, Pantaleo MA. The progressive fragmentation of the KIT\/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST). J Transl Med BioMed Cent. 2017;15:113. https:\/\/doi.org\/10.1186\/s12967-017-1212-x.","journal-title":"J Transl Med BioMed Cent"},{"key":"3698_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/14737140.2015.1032941","volume":"15","author":"S Huss","year":"2015","unstructured":"Huss S, Elges S, Trautmann M, Sperveslage J, Hartmann W, Wardelmann E. Classification of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy. Expert Rev Anticancer Ther. 2015;15:623\u20138. https:\/\/doi.org\/10.1586\/14737140.2015.1032941.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3698_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/S41571-022-00606-4","volume":"19","author":"LR Klug","year":"2022","unstructured":"Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage gastrointestinal stromal tumours. Nat Rev Clin Oncol. Nat Publishing Group. 2022;19:328\u201341. https:\/\/doi.org\/10.1038\/S41571-022-00606-4. Cited 17 Jul 2024.","journal-title":"Nat Rev Clin Oncol [Internet] Nat Publishing Group"},{"key":"3698_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/S12964-023-01411-X","author":"S Zhou","year":"2024","unstructured":"Zhou S, Abdihamid O, Tan F, Zhou H, Liu H, Li Z, et al. KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST. Cell Commun Signal. 2024. https:\/\/doi.org\/10.1186\/S12964-023-01411-X. Cited 22 Jul 2024.","journal-title":"Cell Commun Signal [Internet] Cell Commun Signal"},{"key":"3698_CR7","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1038\/SJ.ONC.1210464","volume":"26","author":"MJ Zhu","year":"2007","unstructured":"Zhu MJ, Ou WB, Fletcher CDM, Cohen PS, Demetri GD, Fletcher JA. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance. Oncogene [Internet] Oncogene. 2007;26:6386\u201395. https:\/\/doi.org\/10.1038\/SJ.ONC.1210464. [cited 2024 Jul 18];.","journal-title":"Oncogene [Internet] Oncogene"},{"key":"3698_CR8","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/SJ.ONC.1207525","volume":"23","author":"A Duensing","year":"2004","unstructured":"Duensing A, Medeiros F, McConarty B, Joseph NE, Panigrahy D, Singer S, et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene Oncogene. 2004;23:3999\u20134006. https:\/\/doi.org\/10.1038\/SJ.ONC.1207525. Cited 18 Jul 2024.","journal-title":"Oncogene Oncogene"},{"key":"3698_CR9","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1038\/SJ.ONC.1210558","volume":"26","author":"S Bauer","year":"2007","unstructured":"Bauer S, Duensing A, Demetri GD, Fletcher JA. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase\/AKT is a crucial survival pathway. Oncogene [Internet] Oncogene. 2007;26:7560\u20138. https:\/\/doi.org\/10.1038\/SJ.ONC.1210558. Cited 18 Jul 2024.","journal-title":"Oncogene [Internet] Oncogene"},{"key":"3698_CR10","doi-asserted-by":"publisher","first-page":"E8448","DOI":"10.1073\/PNAS.1711449114","volume":"114","author":"B Bosbach","year":"2017","unstructured":"Bosbach B, Rossi F, Yozgat Y, Loo J, Zhang JQ, Berrozpe G, et al. Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor. Proc Natl Acad Sci U S A [Internet]. Proc Natl Acad Sci U S A. 2017;114:E8448\u201357. https:\/\/doi.org\/10.1073\/PNAS.1711449114. Cited 18 Jul 2024.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3698_CR11","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-14-1823","volume":"20","author":"T Van Looy","year":"2014","unstructured":"Van Looy T, Wozniak A, Floris G, Sciot R, Li H, Wellens J, et al. Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacy. Clin Cancer Res [Internet] Clin Cancer Res. 2014;20:6071\u201382. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1823. Cited 18 Jul 2024.","journal-title":"Clin Cancer Res [Internet] Clin Cancer Res"},{"key":"3698_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1158\/1078-0432.CCR-12-2853","volume":"19","author":"G Floris","year":"2013","unstructured":"Floris G, Wozniak A, Sciot R, Li H, Friedman L, Van Looy T, et al. A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal. Clin Cancer Res [Internet] Clin Cancer Res. 2013;19:620\u201330. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2853. Cited 18 Jul 2024.","journal-title":"Clin Cancer Res [Internet] Clin Cancer Res"},{"key":"3698_CR13","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-15-2225","volume":"22","author":"SO Dolly","year":"2016","unstructured":"Dolly SO, Wagner AJ, Bendell JC, Kindler HL, Krug LM, Seiwert TY, et al. Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res [Internet] Clin Cancer Res. 2016;22:2874\u201384. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2225. Cited 18 Jul 2024.","journal-title":"Clin Cancer Res [Internet] Clin Cancer Res"},{"key":"3698_CR14","doi-asserted-by":"publisher","unstructured":"Serrano C, George S, Valverde C, Olivares D, Garc\u00eda-Valverde A, Su\u00e1rez C et al. Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors. Target Oncol. 2017;12:277\u201388. https:\/\/doi.org\/10.1007\/S11523-017-0490-9. Cited 18 Jul 2024.","DOI":"10.1007\/S11523-017-0490-9"},{"key":"3698_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1871520619666181127112621","volume":"19","author":"SP Shaik","year":"2019","unstructured":"Shaik SP, Reddy TS, Sunkari S, Rao AVS, Babu KS, Bhargava SK, et al. Synthesis of Benzo[d]imidazo[2,1-b]thiazole-Propenone Conjugates as Cytotoxic and Apoptotic Inducing Agents. Anticancer Agents Med Chem Anticancer Agents Med Chem. 2019;19:347\u201355. https:\/\/doi.org\/10.2174\/1871520619666181127112621. Cited 18 Jul 2024.","journal-title":"Anticancer Agents Med Chem [Internet] Anticancer Agents Med Chem"},{"key":"3698_CR16","doi-asserted-by":"publisher","unstructured":"Shaik SP, Vishnuvardhan MVPS, Sultana F, Subba Rao AV, Bagul C, Bhattacharjee D et al. Design and synthesis of 1,2,3-triazolo linked benzo[d]imidazo[2,1-b]thiazole conjugates as tubulin polymerization inhibitors. Bioorg Med Chem. Elsevier Ltd; 2017;25:3285\u201397. https:\/\/doi.org\/10.1016\/j.bmc.2017.04.013. Cited 7 Feb 2026.","DOI":"10.1016\/j.bmc.2017.04.013"},{"key":"3698_CR17","doi-asserted-by":"publisher","unstructured":"Baig MF, Nayak VL, Budaganaboyina P, Mullagiri K, Sunkari S, Gour J et al. Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents. Bioorg Chem. Academic Press Inc.; 2018;77:515\u201326. https:\/\/doi.org\/10.1016\/j.bioorg.2018.02.005. Cited 7 Feb 2026.","DOI":"10.1016\/j.bioorg.2018.02.005"},{"key":"3698_CR18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/J.BMC.2011.01.039","volume":"19","author":"MS Christodoulou","year":"2011","unstructured":"Christodoulou MS, Colombo F, Passarella D, Ieronimo G, Zuco V, De Cesare M, et al. Synthesis and biological evaluation of imidazolo[2,1-b]benzothiazole derivatives, as potential p53 inhibitors. Bioorg Med Chem Pergamon. 2011;19:1649\u201357. https:\/\/doi.org\/10.1016\/J.BMC.2011.01.039.","journal-title":"Bioorg Med Chem Pergamon"},{"key":"3698_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/JM701246G\/SUPPL_FILE\/JM701246G-FILE002.PDF","volume":"51","author":"A Andreani","year":"2008","unstructured":"Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, et al. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues. J Med Chem Am Chem Soc. 2008;51:809\u201316. https:\/\/doi.org\/10.1021\/JM701246G\/SUPPL_FILE\/JM701246G-FILE002.PDF. Cited 18 Jul 2024.","journal-title":"J Med Chem [Internet] Am Chem Soc"},{"key":"3698_CR20","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1016\/J.EJMECH.2011.07.001","volume":"46","author":"A Andreani","year":"2011","unstructured":"Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, et al. Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors. Eur J Med Chem Eur J Med Chem. 2011;46:4311\u201323. https:\/\/doi.org\/10.1016\/J.EJMECH.2011.07.001. Cited 18 Jul 2024.","journal-title":"Eur J Med Chem [Internet] Eur J Med Chem"},{"key":"3698_CR21","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1016\/j.ejmech.2011.06.031","volume":"46","author":"RM Kumbhare","year":"2011","unstructured":"Kumbhare RM, Vijay Kumar K, Janaki Ramaiah M, Dadmal T, Pushpavalli SNCVL, Mukhopadhyay D, et al. Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo[2,1-b]benzothiazoles as potential anti-cancer agents. Eur J Med Chem Eur J Med Chem. 2011;46:4258\u201366. https:\/\/doi.org\/10.1016\/j.ejmech.2011.06.031. Cited 3 Oct 2025.","journal-title":"Eur J Med Chem [Internet] Eur J Med Chem"},{"key":"3698_CR22","doi-asserted-by":"publisher","unstructured":"Di Vito A, Mandrone M, Chiocchio I, Gorini F, Ravegnini G, Coschina E et al. Arbutus unedo L. Fractions Exhibit Chemotherapeutic Properties for the Treatment of Gastrointestinal Stromal Tumors. Plants (Basel). Plants (Basel); 2024;13. https:\/\/doi.org\/10.3390\/PLANTS13091201. Cited 18 Jul 2024.","DOI":"10.3390\/PLANTS13091201"},{"key":"3698_CR23","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/ACS.JCIM.1C00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S, AutoDock. Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model J Chem Inf Model. 2021;61:3891\u20138. https:\/\/doi.org\/10.1021\/ACS.JCIM.1C00203. Cited 3 Oct 2025.","journal-title":"J Chem Inf Model [Internet] J Chem Inf Model"},{"key":"3698_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/JCC.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/JCC.21334. Cited 3 Oct 2025.","journal-title":"J Comput Chem [Internet] J Comput Chem"},{"key":"3698_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/JCC.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157\u201374. https:\/\/doi.org\/10.1002\/JCC.20035. Cited 3 Oct 2025.","journal-title":"J Comput Chem [Internet] J Comput Chem"},{"key":"3698_CR26","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/ACS.JCTC.5B00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput Am Chem Soc. 2015;11:3696\u2013713. https:\/\/doi.org\/10.1021\/ACS.JCTC.5B00255. Cited 3 Oct 2025.","journal-title":"J Chem Theory Comput [Internet] Am Chem Soc"},{"key":"3698_CR27","doi-asserted-by":"publisher","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VWD et al. AmberTools. J Chem Inf Model. Am Chem Soc. 2023;63:6183. https:\/\/doi.org\/10.1021\/ACS.JCIM.3C01153. Cited 3 Oct 2025.","DOI":"10.1021\/ACS.JCIM.3C01153"},{"key":"3698_CR28","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/CT300418H","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput. 2012;8:3314\u201321. https:\/\/doi.org\/10.1021\/CT300418H. Cited 3 Oct 2025.","journal-title":"J Chem Theory Comput [Internet] J Chem Theory Comput"},{"key":"3698_CR29","unstructured":"Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio) - Monte Westerfield - Google Libri. 4th ed. University of Oregon Press 2000, editor. 2000. https:\/\/books.google.it\/books\/about\/The_Zebrafish_Book.html?id=Iy8PngEACAAJ&redir_esc=y. Cited 5 Dec 2025. Accessed 5 Dec 2025."},{"key":"3698_CR30","doi-asserted-by":"publisher","unstructured":"Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253\u2013310. https:\/\/doi.org\/10.1002\/AJA.1002030302. Cited 5 Dec 2025.","DOI":"10.1002\/AJA.1002030302"},{"key":"3698_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-024-06622-9","author":"R Bra\u00f1as Casas","year":"2024","unstructured":"Bra\u00f1as Casas R, Zuppardo A, Risato G, Dinarello A, Celeghin R, Fontana C, et al. Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment. Cell Death Dis. 2024. https:\/\/doi.org\/10.1038\/S41419-024-06622-9. Cited 5 Dec 2025.","journal-title":"Cell Death Dis [Internet] Cell Death Dis"},{"key":"3698_CR32","doi-asserted-by":"publisher","unstructured":"Facchinello N, Schiavone M, Vettori A, Argenton F, Tiso N. Monitoring Wnt Signaling in Zebrafish Using Fluorescent Biosensors. Methods Mol Biol [Internet]. Methods Mol Biol; 2016 [cited 2025 Dec 5];1481:81\u201394. https:\/\/doi.org\/10.1007\/978-1-4939-6393-5_9.","DOI":"10.1007\/978-1-4939-6393-5_9"},{"key":"3698_CR33","doi-asserted-by":"publisher","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res [Internet]. Nucleic Acids Res; 2019 [cited 2025 Oct 3];47:W357\u20133664. https:\/\/doi.org\/10.1093\/NAR\/GKZ382.","DOI":"10.1093\/NAR\/GKZ382"},{"key":"3698_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI13275","volume":"110","author":"AL Blajeski","year":"2002","unstructured":"Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J Clin Invest Am Soc Clin Invest. 2002;110:91\u20139. https:\/\/doi.org\/10.1172\/JCI13275.","journal-title":"J Clin Invest Am Soc Clin Invest"},{"key":"3698_CR35","doi-asserted-by":"publisher","unstructured":"Zushin PJH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest. Am Soc Cli Investig. 2023;133:e175824. https:\/\/doi.org\/10.1172\/JCI175824.Cited 13 Mar 2025.","DOI":"10.1172\/JCI175824"},{"key":"3698_CR36","doi-asserted-by":"publisher","first-page":"e53708","DOI":"10.1371\/JOURNAL.PONE.0053708","volume":"8","author":"C Godugu","year":"2013","unstructured":"Godugu C, Patel AR, Desai U, Andey T, Sams A, Singh M. AlgiMatrix\u2122 Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies. PLoS One Public Libr Sci. 2013;8:e53708. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0053708. Cited 9 Sep 2024.","journal-title":"PLoS One [Internet] Public Libr Sci"},{"key":"3698_CR37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/J.JBIOSC.2011.01.006","volume":"111","author":"A Oshikata","year":"2011","unstructured":"Oshikata A, Matsushita T, Ueoka R. Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. J Biosci Bioeng. 2011;111:590\u20133. https:\/\/doi.org\/10.1016\/J.JBIOSC.2011.01.006. Cited 9 Sep 2024.","journal-title":"J Biosci Bioeng [Internet] J Biosci Bioeng"},{"key":"3698_CR38","doi-asserted-by":"publisher","unstructured":"Di Vito A, Ravegnini G, Gorini F, Aasen T, Serrano C, Benuzzi E, et al. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib. Pharmacol Ther. Elsevier Inc.; 2023;248. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108475. Cited 7 Feb 2026.","DOI":"10.1016\/j.pharmthera.2023.108475"},{"key":"3698_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2021.11.028","volume":"526","author":"CJ Bell","year":"2022","unstructured":"Bell CJ, Potts KG, Hitt MM, Pink D, Tuszynski JA, Lewis JD. Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma. Cancer Lett. Elsevier. 2022;526:168\u201379. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.028. Cited 21 Feb 2026.","journal-title":"Cancer Lett [Internet] Elsevier"},{"key":"3698_CR40","doi-asserted-by":"publisher","unstructured":"Liu Y, Li Z, Xu Z, Jin X, Gong Y, Xia X et al. Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors. Gastroenterology. W.B. Saunders. 2024;166:450\u2013e46533. https:\/\/doi.org\/10.1074\/mcp.RA119.001361. Cited 20 Feb 2026.","DOI":"10.1074\/mcp.RA119.001361"},{"key":"3698_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/jmg.2009.066944","volume":"46","author":"S Ghavami","year":"2009","unstructured":"Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46:497\u2013510. https:\/\/doi.org\/10.1136\/jmg.2009.066944.Cited 7 Feb 2026.","journal-title":"J Med Genet [Internet] J Med Genet"},{"key":"3698_CR42","doi-asserted-by":"publisher","unstructured":"M\u00e1rquez-Jurado S, D\u00edaz-Colunga J, Das Neves RP, Martinez-Lorente A, Almaz\u00e1n F, Guantes R et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nature Communications 2018;9:1. Nature Publishing Group; 2018;9:389-. https:\/\/doi.org\/10.1038\/s41467-017-02787-4. Cited 7 Feb 2026.","DOI":"10.1038\/s41467-017-02787-4"},{"key":"3698_CR43","doi-asserted-by":"publisher","unstructured":"Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009;459:7245. Nature Publishing Group; 2009. pp. 428\u201332. https:\/\/doi.org\/10.1038\/nature08012. Cited 7 Feb 2026.","DOI":"10.1038\/nature08012"},{"key":"3698_CR44","doi-asserted-by":"publisher","unstructured":"Xia X, Owen MS, Lee REC, Gaudet S. Cell-to-cell variability in cell death: can systems biology help us make sense of it all? Cell Death Dis. 2014;5. https:\/\/doi.org\/10.1038\/cddis.2014.199. Cited 7 Feb 2026.","DOI":"10.1038\/cddis.2014.199"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03698-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:38:10Z","timestamp":1781642290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03698-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3698"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03698-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PBMCs: Authorization to the use of human blood samples (Buffy coat), for research purposes, was obtained from AUSL of Bologna, Italy, S. Orsola-Malpighi Hospital -PROT GEN No. 0051937, and written informed consent was obtained from donors for the use of their blood for scientific research purposes. Zebrafish: All experiments were performed on zebrafish (Danio rerio) (RRID: SCR_007282) embryos and larvae up to 5 days post-fertilization (dpf) in accordance with European Directive 2010\/63\/EU and Italian legislation on animal welfare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}